Dec.

Automated the manufacturing facility for compound liquid formulations.

Aug.

Joint technology partnership with 'ICN' in the United States for the release of Libra, Dalmadorm, and Mestinone.

Jul.

Successful resolution of patent dispute with Landsise.

May

Joint technology partnership with 'BIOTEST' in Germany (Megarotex, Pentaglobin).

Dec.

Registration of patent No, 183183 (Traditional medicine liquid containing cold medicine ingredients)

Mar.

Award the president's commendation on commerce day.

Jan.

Registration of patent No. 111249 (Landsise)

Jul.

Completion of advanced logistics building.

Jan.

Release of Biafine, a dermatological treatment product; through a technology partnership with 'Medix' in France.

Jan.

Commencement of exports to Singapore and Vietnam.

Oct.

Completion of the construction of the central research institute building.

Mar.

Selected as one of top 100 promising small and medium sized enterprises in Gyeonggi province.

Mar.

Completion of automated sewage treatment facility.

Nov.

Designation as an exemption from military service company.

Apr.

Joining the Korea Drug Development Research Association.

Dec.

Awarded the excellence in workplace by Gyeonggi province.

Nov.

Approval for the establishment of the central research institute.

Apr.

Expansion of solid dosage form manufacturing facility.

Mar.

Addition of KGMP-approved facility for external liquid products.

Jan.

Introduction of automated manufacturing facility for liquid products.

Aug.

Open on line connection between Seoul headquarters and Icheon factory, and introduction of computerizing system.

Jul.

Obtained food processing and manufacturing license.

Apr.

Designation as a KGMP-approved facility for comprehensive pharmaceutical manufacturing and management standards (No 64).

Apr.

Commencement of exports to Pakistan.

Jan.

Completion of GMP facility construction and expansion at the factory.

Jan.

Promotion of claim zero campaign.